ArticleClinicoEconomics and outcomes research : CEOR2025

Using QIP-MS to Guide the Timing of MRD Testing in Patients With Multiple Myeloma: A Budget Impact Analysis From the French Payer Perspective.

Christian Siegfried et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.